AKBA

Akebia Therapeut

• Reuters·17h ago

  Akebia Therapeutics director Philip J. Vickers files initial beneficial ownership statement

• Reuters·2d ago

  Akebia names Philip Vickers to board of directors

• Reuters·2d ago

  AKEBIA THERAPEUTICS APPOINTS BIOPHARMACEUTICAL LEADER PHILIP VICKERS, PH.D. TO ITS BOARD OF DIRECTORS

• Dow Jones·2d ago

  Press Release: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors

• NASDAQ·4d ago

  Guardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?

• Reuters·03/25 20:01

  ProKidney appoints Greg Madison chief commercial officer; senior leadership team expands

• Reuters·03/19 20:05

  Akebia Therapeutics to host virtual R&D Day on kidney disease pipeline

• TipRanks·03/09 00:26

  Akebia Therapeutics Earnings Call: Vafseo Drives Growth

• TipRanks·03/06 02:02

  Top Executive Makes Bold Insider Move at Akebia Therapeutics

• Reuters·03/03 13:02

  Akebia Therapeutics to Present at Leerink Partners Global Healthcare Conference

• Reuters·03/02 21:06

  Akebia Therapeutics Grants Inducement Stock Options to Five New Hires

• Reuters·03/02 21:05

  AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·02/27 13:11

  3 Best Biotech Stocks to Buy in Today’s Volatile Market, 2/27/2026, According to Top Analysts

• TipRanks·02/27 11:30

  Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA)

• Seeking Alpha·02/26 16:28

  Akebia outlines 2026 pipeline expansion and expects Vafseo data catalysts in $1B dialysis market